Find information on thousands of medical conditions and prescription drugs.

Tolcapone

Tolcapone, an inhibitor of catechol-O-methyltransferase (COMT), is used in the treatment of Parkinson’s disease as an adjunct to levodopa/carbidopa therapy. It is a yellow, odorless, non-hygroscopic, crystalline compound with a relative molecular mass of 273.25. The chemical name of tolcapone is 3,4-dihydroxy-4’-methyl-5-nitrobenzophenone. Its empirical formula is C14H11NO5.

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

Oxytetracycline

Thiopental sodium

Tranexamic acid

Tranylcypromine

Triamcinolone hexacetonide

Triclabendazole

Trifluoperazine

Tubocurarine chloride

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	AHRQ report on treatment of Parkinson's disease - Clinical Briefs Agency for Healthcare Research and Quality The Agency for Healthcare Research and Quality has released a new evidence report on Parkinson's disease. "Diagnosis and Treatment of Parkinson's Disease: ... From American Family Physician, 11/1/03 by Carrie Morantz

	Serious Liver Injury - drug-induced liver injury Leading Reason For Drug Removals, Restrictions People who experience acute liver failure become critically ill in a matter of days, with most cases ... From FDA Consumer, 5/1/01 by Michelle Meadows

	Parkinson's disease Parkinson's disease (PD) is a progressive movement disorder marked by tremor, rigidity, slow movements (bradykinesia), and postural instability. It occurs ... From Gale Encyclopedia of Medicine, 4/6/01 by Richard Robinson

	Parkinson's disease Parkinson's disease (PD) is a progressive movement disorder marked by tremors, rigidity, slow movements (bradykinesia), and postural instability. It occurs ... From Gale Encyclopedia of Alternative Medicine, 4/6/01 by Paula Ford-Martin

	Parkinson's Disease as Multifactorial Oxidative Neurodegeneration: Implications for Integrative Management Abstract Parkinson's disease (PD) is the most common movement pathology, severely afflicting dopaminergic neurons within the substantia nigra (SN) ... From Alternative Medicine Review, 12/1/00 by Parris M. Kidd

	Parkinson's Disease: The Treatment Options. - Review - book reviews Parkinson's Disease: The Treatment Options Wolfgang Oertel, Peter LeWitt Martin Dunitz, 65 [pounds sterling], pp 272 ISBN 1 85317 379 7 Rating: *** ... From British Medical Journal, 10/23/99 by Herve Allain

	Liver Risk Warning Added to Parkinson's Drug - drug Tasmar must have warning label - Brief Article FDA and the maker of Tasmar (tolcapone), a drug for treating Parkinson's disease, have warned doctors about three fatal liver injuries associated with ... From FDA Consumer, 3/1/99

	Parkinson's disease - Science, Medicine, and the Future Research is continuing on new drugs for Parkinson's disease. Parkinson's disease is caused by the death of nerve cells in an area of the brain called the ... From British Medical Journal, 1/30/99 by A H V Schapira

Home

Contact

Resources

ebay